Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2010 2
2012 2
2013 5
2014 5
2015 4
2016 2
2017 2
2018 1
2019 2
2020 3
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
AP-2α-Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis.
White JR, Thompson DT, Koch KE, Kiriazov BS, Beck AC, van der Heide DM, Grimm BG, Kulak MV, Weigel RJ. White JR, et al. Among authors: kulak mv. Cancer Res. 2021 Sep 1;81(17):4455-4470. doi: 10.1158/0008-5472.CAN-21-0772. Epub 2021 Jul 1. Cancer Res. 2021. PMID: 34210752 Free PMC article.
AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells.
Gu VW, Cho E, Thompson DT, Cassady VC, Borcherding N, Koch KE, Wu VT, Lorenzen AW, van der Heide DM, White JR, Kulak MV, Williams T, Zhang W, Weigel RJ. Gu VW, et al. Among authors: kulak mv. Stem Cell Reports. 2021 Jan 12;16(1):106-119. doi: 10.1016/j.stemcr.2020.12.002. Epub 2020 Dec 30. Stem Cell Reports. 2021. PMID: 33382976 Free PMC article.
TFAP2C regulates carbonic anhydrase XII in human breast cancer.
Franke CM, Gu VW, Grimm BG, Cassady VC, White JR, Weigel RJ, Kulak MV. Franke CM, et al. Among authors: kulak mv. Oncogene. 2020 Feb;39(6):1290-1301. doi: 10.1038/s41388-019-1062-5. Epub 2019 Oct 21. Oncogene. 2020. PMID: 31636386
A novel HER2 gene body enhancer contributes to HER2 expression.
Liu Q, Kulak MV, Borcherding N, Maina PK, Zhang W, Weigel RJ, Qi HH. Liu Q, et al. Among authors: kulak mv. Oncogene. 2018 Feb 1;37(5):687-694. doi: 10.1038/onc.2017.382. Epub 2017 Oct 16. Oncogene. 2018. PMID: 29035388 Free PMC article.
A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer.
Wu VT, Kiriazov B, Koch KE, Gu VW, Beck AC, Borcherding N, Li T, Addo P, Wehrspan ZJ, Zhang W, Braun TA, Brown BJ, Band V, Band H, Kulak MV, Weigel RJ. Wu VT, et al. Among authors: kulak mv. Mol Cancer Res. 2020 Jan;18(1):46-56. doi: 10.1158/1541-7786.MCR-19-0359. Epub 2019 Oct 16. Mol Cancer Res. 2020. PMID: 31619506 Free PMC article.
A novel animal model for locally advanced breast cancer.
Bogachek MV, Park JM, De Andrade JP, Kulak MV, White JR, Wu T, Spanheimer PM, Bair TB, Olivier AK, Weigel RJ. Bogachek MV, et al. Among authors: kulak mv. Ann Surg Oncol. 2015 Mar;22(3):866-73. doi: 10.1245/s10434-014-4174-8. Epub 2014 Oct 18. Ann Surg Oncol. 2015. PMID: 25326397 Free PMC article.
Sumoylation pathway is required to maintain the basal breast cancer subtype.
Bogachek MV, Chen Y, Kulak MV, Woodfield GW, Cyr AR, Park JM, Spanheimer PM, Li Y, Li T, Weigel RJ. Bogachek MV, et al. Among authors: kulak mv. Cancer Cell. 2014 Jun 16;25(6):748-61. doi: 10.1016/j.ccr.2014.04.008. Epub 2014 May 15. Cancer Cell. 2014. PMID: 24835590 Free PMC article.
EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
De Andrade JP, Park JM, Gu VW, Woodfield GW, Kulak MV, Lorenzen AW, Wu VT, Van Dorin SE, Spanheimer PM, Weigel RJ. De Andrade JP, et al. Among authors: kulak mv. Mol Cancer Ther. 2016 Mar;15(3):503-11. doi: 10.1158/1535-7163.MCT-15-0548-T. Epub 2016 Feb 1. Mol Cancer Ther. 2016. PMID: 26832794 Free PMC article.
27 results